141 related articles for article (PubMed ID: 9886600)
1. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia.
Giovannucci E; Platz EA; Stampfer MJ; Chan A; Krithivas K; Kawachi I; Willett WC; Kantoff PW
Urology; 1999 Jan; 53(1):121-5. PubMed ID: 9886600
[TBL] [Abstract][Full Text] [Related]
2. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.
Giovannucci E; Stampfer MJ; Chan A; Krithivas K; Gann PH; Hennekens CH; Kantoff PW
Prostate; 1999 May; 39(2):130-4. PubMed ID: 10221569
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth.
Mitsumori K; Terai A; Oka H; Segawa T; Ogura K; Yoshida O; Ogawa O
Prostate; 1999 Dec; 41(4):253-7. PubMed ID: 10544298
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer.
Tan JSJ; Ong KC; Ong DBL; Wu YS; Razack A; Kuppusamy S; Lim J; Rhodes A
Malays J Pathol; 2019 Dec; 41(3):243-251. PubMed ID: 31901908
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial.
Kristal AR; Price DK; Till C; Schenk JM; Neuhouser ML; Ockers S; Lin DW; Thompson IM; Figg WD
Prostate; 2010 May; 70(6):584-90. PubMed ID: 19938041
[TBL] [Abstract][Full Text] [Related]
6. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
Akinloye O; Gromoll J; Simoni M
Br J Biomed Sci; 2011; 68(3):138-42. PubMed ID: 21950206
[TBL] [Abstract][Full Text] [Related]
7. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
[TBL] [Abstract][Full Text] [Related]
8. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor CAG polymorphism and the risk of benign prostatic hyperplasia in a Brazilian population.
Biolchi V; Silva Neto B; Koff W; Brum IS
Int Braz J Urol; 2012; 38(3):373-9. PubMed ID: 22765868
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor CAG repeat length polymorphism associates with prostate volume in Finnish men with benign prostatic hyperplasia.
Renko O; Savolainen ER; Loikkanen I; Paavonen TK; Vaarala MH
DNA Cell Biol; 2008 Feb; 27(2):109-13. PubMed ID: 17979523
[TBL] [Abstract][Full Text] [Related]
11. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of androgen receptor CAG repeats with the risks of benign prostatic hyperplasia and prostate cancer: a meta-analysis].
Wang XM; Sun L; Zhang Z; Shi XH; Zhang YG; Wei D; Wan B; Yang Z; Wang JY
Zhonghua Nan Ke Xue; 2014 Feb; 20(2):172-6. PubMed ID: 24520673
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor CAG polymorphism and prostate cancer risk.
Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.
Sircar K; Gottlieb B; Alvarado C; Aprikian A; Beitel LK; Alam-Fahmy M; Begin L; Trifiro M
Prostate Cancer Prostatic Dis; 2007; 10(4):360-8. PubMed ID: 17440439
[TBL] [Abstract][Full Text] [Related]
15. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
[TBL] [Abstract][Full Text] [Related]
16. Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia.
Tayeb MT; Clark C; Murray GI; Sharp L; Haites NE; McLeod HL
Ann Saudi Med; 2004; 24(1):21-6. PubMed ID: 15310009
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia.
Bousema JT; Bussemakers MJ; van Houwelingen KP; Debruyne FM; Verbeek AL; de La Rosette JJ; Kiemeney LA
Eur Urol; 2000 Feb; 37(2):234-8. PubMed ID: 10705205
[TBL] [Abstract][Full Text] [Related]
19. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines.
Beilin J; Ball EM; Favaloro JM; Zajac JD
J Mol Endocrinol; 2000 Aug; 25(1):85-96. PubMed ID: 10915221
[TBL] [Abstract][Full Text] [Related]
20. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
